## CHRW: C.H. Robinson Worldwide, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 1.5% below STRENGTH zone (3.0-6.0%); PEG 2.26 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($161.28)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. C.H. Robinson Fourth Quarter 2025 Earnings Release and Conference Call Scheduled for Wednesday, January 28, 2026**
- Source: Business Wire | 20260106T212121 | Neutral | Relevance: 100%
- C.H. Robinson Worldwide, Inc. (Nasdaq: CHRW) announced its fourth quarter 2025 earnings release will be issued after market close on Wednesday, January 28, 2026. The company will host a conference call at 5:30 p.m. Eastern Time on the same day to discuss results and answer investor questions. A simultaneous audio webcast and presentation slides will be available on their investor relations website.

**2. CH Robinson Worldwide stock hits all-time high at 167.91 USD**
- Source: Investing.com Australia | 20260106T150803 | Bullish | Relevance: 100%
- CH Robinson Worldwide Inc.'s stock reached an all-time high of $167.91, reflecting a 60.7% increase over the past year and strong investor confidence. The logistics company has a market cap of $19.75 billion, a P/E ratio of 33.81, and has maintained dividend payments for 29 consecutive years. Despite anticipating a sales decline, recent Q3 2025 earnings surpassed expectations, and several analysts have upgraded the stock, citing successful AI investments and market positioning.

**3. Generali Asset Management SPA SGR Purchases 16,354 Shares of C.H. Robinson Worldwide, Inc. $CHRW**
- Source: MarketBeat | 20260105T060800 | Somewhat-Bullish | Relevance: 100%
- Generali Asset Management SPA SGR significantly increased its stake in C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) during the third quarter of last year, adding 16,354 shares to effectively boost its position by 1,393%. This move brings their total holdings to 17,528 shares valued at approximately $2.32 million. Despite notable insider selling from executives Angela K. Freeman and Michael D. Castagnetto, who reduced their holdings by 43.15% and 57.07% respectively, analyst sentiment remains largely positive with a "Moderate Buy" consensus and an average price target of $149.48.

**4. CH Robinson Worldwide stock hits all-time high at 167.91 USD**
- Source: Investing.com | 20260106T145146 | Bullish | Relevance: 100%
- CH Robinson Worldwide Inc. (CHRW) stock has reached an all-time high of $167.91, surpassing its 52-week high and representing a 60.7% increase over the past year. This growth is supported by strong investor confidence, impressive returns, and recent positive financial news including exceeding Q3 2025 earnings expectations and increased dividends. The company continues to demonstrate successful strategies and operational strength in the logistics sector.

**5. C.H. Robinson Worldwide (NASDAQ:CHRW) Insider Michael John Short Sells 2,390 Shares**
- Source: MarketBeat | 20260105T222644 | Neutral | Relevance: 100%
- C.H. Robinson Worldwide (NASDAQ:CHRW) insider Michael John Short recently sold 2,390 shares of the company's stock for $386,964.90, reducing his stake by 4.15%. The company also announced a quarterly dividend increase to $0.63 per share, and reported mixed third-quarter results with EPS beating estimates but revenue declining year-over-year.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-06 | Wells Fargo | $185 | $170 | +9% |
| 2025-12-24 | B of A Securiti | $182 | $167 | +9% |
| 2025-12-16 | Stifel | $184 | $155 | +19% |
| 2025-12-16 | Barclays | $200 | $145 | +38% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-06 | Wells Fargo | main | Overweight |
| 2025-12-24 | B of A Securiti | main | Buy |
| 2025-12-16 | Stifel | main | Buy |
| 2025-12-16 | Barclays | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($1.79M) |
| Sells | 2 ($0.38M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 54.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.0% (-3.0%)
- First Eagle Investme: 8.9% (-0.2%)
- Blackrock Inc.: 8.2% (-8.5%)
- Wellington Managemen: 6.1% (+198.6%)
- State Street Corpora: 5.8% (-7.4%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 5 raises (avg +17%) could attract flows.
- Momentum building: MRS_10 improving +2.9% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.26 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 34%). Analyst sentiment positive (5 raises, avg +17%). Insider buying signal ($1.8M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.8B |
| Beta | 0.91 |
| 52W Range | $84.68 - $168.17 |
| Short Interest | 6.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.26 |
| Forward P/E | 28.0 |
| Current P/E | 33.6 |
| YoY Growth | 20.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.4% to 1.5% (+2.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.5pp (needs >3.0% for momentum thesis). MRS_5 at 1.3% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.54% (CS: 54) | Neutral |
| RSI_14 | 66.2 | Neutral |
| MACD Histogram | -0.12 | Bearish |
| vs SMA20 | 1.037x | Above |
| vs SMA50 | 1.081x | Above |
| vs SMA200 | 1.398x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $167.66
- **Stop Loss:** $161.28 (3.8% risk)
- **Target:** $174.04 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 206
- **Position Value:** $34,537.96
- **Portfolio %:** 34.54%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-01-28 (Est: $1.13)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.40 | +7.4% |
| 2025Q2 | $1.16 | $1.29 | +11.6% |
| 2025Q1 | $1.05 | $1.17 | +11.4% |
| 2024Q4 | $1.11 | $1.21 | +9.2% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_10*